NIH-funded research R01 grant

Identifying protective antibody responses to malaria in children

Official title: Identifying functional antibody responses that protect against malaria in children

Funded at Michigan State University · NIH-11554571 · Data updated 2026-11-12

Young children in Africa may develop antibodies that protect against malaria; this project maps which antibody features help prevent severe disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startAugust 15, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$158,782
NIH project number3R01AI165595-05S1
Project IDNIH-11554571 on NIH RePORTER

Who could benefit from this research

Could help

Children in malaria-endemic areas, especially those with varying severity of malaria and ages 0-11 years.

Less likely to help

Children without malaria exposure or those not contributing samples or data may not benefit directly.

What this research studies

Researchers in Blantyre, Malawi, will study how children’s antibodies recognize malaria parasites and which antibody traits correlate with protection or severe illness. They will profile antibodies against PfEMP1, a key malaria protein, using systems serology and machine learning to identify patterns associated with cerebral malaria and asymptomatic infection. The study compares children with cerebral malaria, those with retinal or brain involvement, and those who clear infections without symptoms, tracking changes from acute illness to recovery. By focusing on how the immune system responds to specific parasite variants, the work aims to reveal targets for vaccines or therapies that reduce severe malaria. The project is based at Michigan State University with local collaborations in Malawi and uses blood samples and clinical data from participating children.

Why it matters

Potential benefit: If successful, the work could inform vaccine design and interventions that steer antibody responses toward protective profiles.

How similar studies have gone: Previous studies using systems serology have linked antibody profiles to protection in malaria, but this project advances by linking specific PfEMP1 targets to clinical outcomes.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Seydel, Karl Boynton — Michigan State University
  • Study coordinator: Seydel, Karl Boynton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.